[{"Assets_0_Q2_USD":473975000.0,"CommonStockSharesOutstanding_0_Q2_shares":518902349.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-87597000.0,"NetIncomeLoss_2_Q2_USD":-111168000.0,"NetIncomeLoss_1_Q2_USD":-60545000.0,"StockholdersEquity_0_Q2_USD":255753000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]